Merck claims hepatitis C patent win

23-03-2016

Merck claims hepatitis C patent win

Gil C / Shutterstock.com

A US court has upheld the validity of two patents owned by Merck in the pharmaceutical company’s dispute with drug maker Gilead centring on hepatitis C treatments.


Merck, Gilead, hepatitis C, patent infringement, Harvoni, Sovaldi

LSIPR